Pinnacle Financial Partners (Tennessee)
REGN icon

Pinnacle Financial Partners (Tennessee)’s Regeneron Pharmaceuticals REGN Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-212
Closed -$223K – 527
2024
Q3 		$223K Buy
212
+18
+9% +$20K ﹤0.01% 418
2024
Q2 		$204K Buy
+194
New +$188K ﹤0.01% 431
2016
Q1 		– Sell
-960
Closed -$521K – 266
2015
Q4 		$521K Buy
960
+32
+3% +$17.3K 0.16% 149
2015
Q3 		$432K Hold
928
– – 0.14% 151
2015
Q2 		$473K Hold
928
– – 0.15% 143
2015
Q1 		$419K Sell
928
-577
-38% -$245K 0.14% 148
2014
Q4 		$617K Hold
1,505
– – 0.22% 119
2014
Q3 		$543K Sell
1,505
-290
-16% -$97.2K 0.21% 116
2014
Q2 		$507K Hold
1,795
– – 0.2% 118
2014
Q1 		$539K Hold
1,795
– – 0.24% 106
2013
Q4 		$494K Sell
1,795
-35
-2% -$10.1K 0.23% 108
2013
Q3 		$572K Buy
1,830
+250
+16% +$65.8K 0.28% 87
2013
Q2 		$355K Buy
+1,580
New +$368K 0.18% 96

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s REGN Position: Q4 2024 in Review

Pinnacle Financial Partners (Tennessee) sold out of Regeneron Pharmaceuticals (REGN) in Q4 2024, closing a stake of 212 shares — an estimated $223K sold.

Pinnacle Financial Partners (Tennessee) first reported a position in REGN in Q2 2013 and held it in 13 quarters. The position peaked at $617K in Q4 2014. 1,321 funds tracked by Wall St. Rank hold REGN as of Q4 2024.

  • Pinnacle Financial Partners (Tennessee) reported no remaining Regeneron Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Pinnacle Financial Partners (Tennessee) sold 212 Regeneron Pharmaceuticals shares in Q4 2024, an estimated $223K.
  • Pinnacle Financial Partners (Tennessee) first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 13 quarters.
  • Pinnacle Financial Partners (Tennessee)'s Regeneron Pharmaceuticals position peaked at $617K in Q4 2014.
  • 1,321 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q4 2024, filed 3 Feb 2025.